Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of linezolid and meropenem during continuous renal replacement therapy
2013-000899-16Phase 4Active
- Sponsor
- University Medical Center Mainz
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of linezolid and meropenem in bacterial disease and sepsis (2 cohorts), sponsored by University Medical Center Mainz. Primary endpoint: 24-hour blood and dialysate pharmacokinetic sampling. Started Sep 2013; status: active.
02
Drugs
linezolidmeropenem
03
Conditions
bacterial diseasesepsis
Beyond the preview
Go deeper on 2013-000899-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000899-16.